CM Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

CM Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100,000	Closed	-$610K	–	102
2021 Q3	$610K	Buy	100,000 +25,000	+33%	+$156K	0.45%	67
2021 Q2	$617K	Hold	75,000	–	–	0.45%	68
2021 Q1	$671K	Hold	75,000	–	–	0.5%	69
2020 Q4	$866K	Buy	+75,000	New	+$872K	0.8%	44

CM Management's FLXN Position: Q4 2021 in Review

CM Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 100,000 shares — an estimated $610K sold.

CM Management first reported a position in FLXN in Q4 2020 and held it in 4 quarters. The position peaked at $866K in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

CM Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
CM Management sold 100,000 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $610K.
CM Management first reported a position in Flexion Therapeutics, Inc. in Q4 2020 and held it in 4 quarters.
CM Management's Flexion Therapeutics, Inc. position peaked at $866K in Q4 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on CM Management's 13F filing for Q4 2021, filed 2 Feb 2022.